SPORTS MEDICINE

ULTRABUTTON^◊ Adjustable Fixation Device Family

Ultra-strong knee ligament fixation solutions*^1-5

All grafts, all adjustable, all secure

Building on more than 25 years of experience in cortical fixation technology, the ULTRABUTTON Adjustable Fixation Device Family offers ultra-strong^*1-4 fixation with low displacement during cyclic loading.^*1,2,5-8

Featuring low-profile^1,2,9,10 titanium buttons and expressly designed for graft protection, the expanded range offers dedicated solutions for all graft types and knee locations:

Quadriceps tendon: The ULTRABUTTON QUAD Device offers integrated button fixation and suture management with an average graft preparation time of under 4 minutes^**7 and greater mean repair strength^***1,11

Bone-tendon-bone (BTB) and quad tendon-bone (QT-B): The ULTRABUTTON BB Device features an open loop design to facilitate graft attachment in under 2 minutes,^**12 shown to offer a stronger mean repair in bone block femoral fixation^****11

Hamstring: The ULTRABUTTON Device’s large contact area helps to protect the graft, with interlocking adjustment requiring minimal force to reduce the loop^13-17 while maximising graft in the tunnel

Tibial fixation:The ULTRABUTTON TIB Device is available in three sizes to accommodate common tunnel diameters and is suitable for quadriceps and hamstring grafts. An ultra-low profile small button¹⁸ facilitates all-inside techniques and medium/large sizes are preassembled for fewer technique steps

Product Features

Surgical Techniques

Show Videos

The ULTRABUTTON Adjustable Fixation Device can be used to conduct the UltraTRAC, UltraSTAR and UltraSURE techniques.

UltraTRAC Quad Technique
The UltraTRAC Quad ACL reconstruction technique utilises a soft tissue quadriceps graft, reproducibly^20,21 harvested with the QUADTRAC^◊ Quadriceps Tendon Harvest Guide System and easily prepared with just 5 needle passes¹² on the X-WING Graft Preparation System with the ultra-strong^*1-4 ULTRABUTTON Adjustable Fixation Device Family.
UltraSTAR Technique
The UltraSTAR ACL reconstruction technique uses a single, quadrupled semitendinosus graft, where less hamstring is harvested. Use of the semitendinosus graft is linked with reduced donor-site morbidity, compared to traditional dual-hamstring tendon techniques.²² The technique also allows for preparation of large diameter grafts that are associated with improved outcomes.^23-25 UltraSTAR features a double ULTRABUTTON construct which has shown low displacement during cyclic loading.^*1,2,5-8 This can all be done while using your current trusted drilling technique.
UltraSURE Technique
UltraSURE enables the use of a semitendinosis and gracilis graft - the most commonly used graft in the industry for ACL reconstruction.^27,28 It utilises two trusted fixation technologies with the ULTRABUTTON Adjustable Fixation Device loop and the advanced biocomposite screw, BIOSURE^◊ REGENESORB^◊ Screw. The ULTRABUTTON Device is designed to protect the graft with its graft cradle and allows for fine-tuning and tensioning before final fixation while the open architecture of the BIOSURE REGENESORB screw supports boney ingrowth and circumferential graft-to-bone integration (as demonstrated in vivo).²⁹ Drilling options provide the ability to use single fluted reamers, with the aim of minimising iatrogenic damage to the femoral condyle when drilling

Download PDF

Reference Materials

Medical Education

No results.

Related Products

Disclaimer

*As demonstrated in benchtop testing.

**n=5.

***ULTRABUTTON QUAD Adjustable Fixation Device, compared to Arthrex ACL Fibertag™ Tightrope™ implant in benchtop testing; p<0.05.

****ULTRABUTTON BB Adjustable Fixation Device, compared to Arthrex BTB Tightrope™ Implant and Zimmer Biomet ToggleLoc Femoral Fixation Device with Ziploop™ Technology for BTB grafts in benchtop testing.

*****As demonstrated in bench top testing, compared to TightRope, ToggleLoc and GraftMax.

******As demonstrated in bench top testing; compared to TightRope RT, GraftMax and ProCinch.

For detailed product information, including indications for use, contraindications, precautions and warnings, please consult the product’s applicable Instructions for Use (IFU) prior to use.

Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Smith+Nephew representative or distributor if you have questions about the availability of Smith+Nephew products in your area.

Citations

Arthrocare Corporation 2016. Internal Report. P/N 69889-01 C.
Ahmad, S, et al. Knee Surg Sports Traumatol Arthrosc, 2018; 26(5):1932-1398.
Shelburne, KB, et al. J Biomech, 2004; 37(6): 797-805.
Smith+Nephew 2022. Internal Report. 15012185 Rev A.
Smith+Nephew 2022. Internal Report. 15011545 Rev A.
Smith+Nephew 2022. Internal Report. 15011463 Rev A.
Arthrocare Corporation 2018. Internal Report. P/N 69889-01 F.
Arthrocare Corporation 2018. Internal Report. P/N 69889-01 D.
Smith+Nephew 2022. Internal Report. 15012076.
Smith+Nephew 2022. Internal Report. 15011883 Rev A.
Smith+Nephew 2022. Internal Report. 15012185 Rev A.
Smith+Nephew 2022. Internal Report. 15012018 Rev A.
Smith+Nephew 2016. Internal Report. P/N 68688-01 B.
Arthrocare Corporation 2015. Internal Report. P/N 65492-01 B.
Smith+Nephew 2022. Internal Report. 15011670 Rev A.
Smith+Nephew 2022. Internal Report. 1501147 Rev A.
Smith+Nephew 2022. Internal Report. 15011448 Rev A.
Smith+Nephew.com 2022. Internal Report. 15012083 Rev A.
Smith+Nephew 2022. Internal Report. 150169 Rev A.
Smith+Nephew 2022. Internal Report. 15011552 Rev A.
Smith+Nephew 2022. Internal Report. 15011559 Rev A.
Sengoku T, et al. Archives of Orthopaedic and Trauma Surgery. Published online April 2, 2021.
Sherman O. Arthroscopy. 2021; 37:586-587.
Snaebjornsson T, et al. Am J Sports Med. 2017;45:2092-2097.
Spragg L, et al. Am J Sports Med. 2016;44:1475-1481.
Vonhoegen J, et al. Orthop Traumatol Surg Res. 2019;14(1):12.
Widner M, et al. Current Reviews in Musculoskeletal Medicine, 2019.1029; 12:460-465.
Tibor L, et al. J Bone Joint Surg Am. 2016;98:1079-89.
Smith+Nephew 2015. Internal Report. NCS250.